Synthesis and structure-activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase

被引:64
|
作者
Toth, Marietta [1 ]
Kun, Sandor [1 ]
Bokor, Eva [1 ]
Benltifa, Mahmoud [2 ,3 ,4 ]
Tallec, Gaylord [2 ,3 ,4 ]
Vidal, Sebastien [2 ,3 ,4 ]
Docsa, Tibor [5 ]
Gergely, Pal [6 ]
Somsak, Laszlo [1 ]
Praly, Jean-Pierre [2 ,3 ,4 ]
机构
[1] Univ Debrecen, Dept Organ Chem, H-4010 Debrecen, Hungary
[2] Univ Lyon, Inst Chim & Biochim Mol & Supramol, CNRS, Lab Chim Organ 2,UMR 5246, F-69622 Villeurbanne, France
[3] Univ Lyon 1, F-69622 Villeurbanne, France
[4] CPE Lyon, F-69616 Villeurbanne, France
[5] Univ Debrecen, Cell Biol & Signaling Res Grp, Hungarian Acad Sci, Dept Med Chem,Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
[6] Univ Debrecen, Dept Med Chem, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
基金
匈牙利科学研究基金会;
关键词
C-Glycosyl compounds; 1,3,4-Oxadiazoles; 1,2,4-Oxadiazoles; Glycogen phosphorylase; Inhibitors; TYPE-2; DIABETES-MELLITUS; 2,5-DISUBSTITUTED 1,3,4-OXADIAZOLES; ANTIDIABETIC AGENTS; EVOLVING EPIDEMIC; TARGETS; BINDING; MUSCLE; CYANIDES; THERAPY; AMIDES;
D O I
10.1016/j.bmc.2009.04.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of per-O-benzoylated 5-beta-D-glucopyranosyl-2-substituted-1,3,4-oxadiazoles was prepared by acylation of the corresponding 5-(beta-D-glucopyranosyl) tetrazole. As an alternative, oxidation of 2,6-anhydro-aldose benzoylhydrazones by iodobenzene I, I-diacetate afforded the same oxadiazoles. 1,3-Dipolar cycloaddition of nitrile oxides to per-O-benzoylated beta-D-glucopyranosyl cyanide gave the corresponding 5-beta-D-glucopyranosyl-3-substituted-1,2,4-oxadiazoles. The O-benzoyl protecting groups were removed by base-catalyzed transesterification. The 1,3,4-oxadiazoles were practically inefficient as inhibitors of rabbit muscle glycogen phosphorylase b while the 1,2,4-oxadiazoles displayed inhibitory activities in the micromolar range. The best inhibitors were the 5-beta-D-glucopyranosyl-3-(4-methylphenyl-and -2-naphthyl)- 1,2,4-oxadiazoles (K-i = 8.8 and 11.6 mu M, respectively). A detailed analysis of the structure-activity relationships is presented. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4773 / 4785
页数:13
相关论文
共 50 条
  • [31] Quantitative structure-activity relationships of dihydrofolatereductase inhibitors
    Zare-Shahabadi, Vahid
    MEDICINAL CHEMISTRY RESEARCH, 2016, 25 (12) : 2787 - 2797
  • [32] Quantitative structure-activity relationships of molting inhibitors
    Nakagawa, Y
    JOURNAL OF PESTICIDE SCIENCE, 1996, 21 (03) : 363 - 377
  • [33] Quantitative Structure-Activity Relationships of Renin Inhibitors
    Gupta, Satya P.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2003, 3 (04) : 315 - 321
  • [34] Corrosion inhibitors:: Quantitative structure-activity relationships
    Lukovits, I
    Shaban, A
    Kálmán, E
    RUSSIAN JOURNAL OF ELECTROCHEMISTRY, 2003, 39 (02) : 177 - 181
  • [35] Synthesis and structure-activity relationship of imidazoquinolone based inhibitors of glycogen synthase kinase 3β
    Li, Bei
    Li, Qiang
    Okerberg, Eric
    Nomanbhoy, Tyzoon
    Cociorva, Oana
    Nakamura, Kai
    Liyanage, Marek
    Zhang, Melissa C.
    Szardenings, Anna Katrin
    Kozarich, John W.
    Shreder, Kevin R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [36] Synthesis and structure-activity relationships of teixobactin
    Karas, John A.
    Chen, Fan
    Schneider-Futschik, Elena K.
    Kang, Zhisen
    Hussein, Maytham
    Swarbrick, James
    Hoyer, Daniel
    Giltrap, Andrew M.
    Payne, Richard J.
    Li, Jian
    Velkov, Tony
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1459 (01) : 86 - 105
  • [37] Structure-activity analysis of the purine binding site of human liver glycogen phosphorylase
    Ekstrom, JL
    Pauly, TA
    Carty, MD
    Soeller, WC
    Culp, J
    Danley, DE
    Hoover, DJ
    Treadway, JL
    Gibbs, EM
    Fletterick, RJ
    Day, YSN
    Myszka, DG
    Rath, VL
    CHEMISTRY & BIOLOGY, 2002, 9 (08): : 915 - 924
  • [38] Synthesis, Structure-Activity Relationships and Biological Activity of New Isatin Derivatives as Tyrosinase Inhibitors
    Gencer, Nahit
    Sonmez, Fatih
    Demir, Dudu
    Arslan, Oktay
    Kucukislamoglu, Mustafa
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (12) : 1450 - 1462
  • [39] Novel Hepatitis C virus replicon inhibitors: Synthesis and structure-activity relationships of fused pyrimidine derivatives
    Krueger, A. Chris
    Madigan, Darold L.
    Beno, David W.
    Betebenner, David A.
    Carrick, Robert
    Green, Brian E.
    He, Wenping
    Liu, Dachun
    Maring, Clarence J.
    McDaniel, Keith F.
    Mo, Hongmei
    Molla, Akhteruzzaman
    Motter, Christopher E.
    Pilot-Matias, Tami J.
    Tufano, Michael D.
    Kempf, Dale J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (06) : 2212 - 2215
  • [40] SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF BACTERIOCINS
    Vederas, J.
    BIOPOLYMERS, 2009, 92 (04) : 303 - 303